106 related articles for article (PubMed ID: 2788827)
1. Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2.
Watts RG; Wright JL; Atkinson LL; Merchant RE
Neurosurgery; 1989 Aug; 25(2):202-8. PubMed ID: 2788827
[TBL] [Abstract][Full Text] [Related]
2. Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma.
Watts RG; Merchant RE
Neurosurgery; 1992 Jul; 31(1):89-98; discussion 98-9. PubMed ID: 1641114
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion.
Ellison MD; Povlishock JT; Merchant RE
Cancer Res; 1987 Nov; 47(21):5765-70. PubMed ID: 3499219
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat.
Wright JL; Merchant RE
J Neurooncol; 1994; 20(1):17-25. PubMed ID: 7807180
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.
Kido G; Wright JL; Merchant RE
J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671
[TBL] [Abstract][Full Text] [Related]
6. Effects of an intratumoral injection of human recombinant tumor necrosis factor-alpha on cerebrovascular permeability and leukocytic infiltration in a rat glioma model.
Wright JL; Merchant RE
Acta Neuropathol; 1997 Jan; 93(1):78-86. PubMed ID: 9006660
[TBL] [Abstract][Full Text] [Related]
7. Differential central nervous system responses following single and multiple recombinant interleukin-2 infusions.
Ellison MD; Krieg RJ; Povlishock JT
J Neuroimmunol; 1990 Aug; 28(3):249-60. PubMed ID: 2373762
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant interleukin-2 provokes acute pulmonary vascular endothelial injury in rabbits.
Goldblum SE; Yoneda K; Cibull M; Pearson T; Hall C; Marshall ME
J Biol Response Mod; 1990 Apr; 9(2):127-39. PubMed ID: 2160520
[TBL] [Abstract][Full Text] [Related]
9. Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-alpha in the rat.
Wright JL; Merchant RE
Acta Neuropathol; 1992; 85(1):93-100. PubMed ID: 1285500
[TBL] [Abstract][Full Text] [Related]
10. Breakdown of the blood-brain barrier and neuropathological changes induced by Phoneutria nigriventer spider venom.
de Paula Le Sueur L; Kalapothakis E; da Cruz-Höfling MA
Acta Neuropathol; 2003 Feb; 105(2):125-34. PubMed ID: 12536223
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
12. A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.
Weiss GR; Margolin KA; Aronson FR; Sznol M; Atkins MB; Dutcher JP; Gaynor ER; Boldt DH; Doroshow JH; Bar MH
J Clin Oncol; 1992 Feb; 10(2):275-81. PubMed ID: 1732429
[TBL] [Abstract][Full Text] [Related]
13. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
Papa MZ; Mulé JJ; Rosenberg SA
Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study.
Blamire AM; Anthony DC; Rajagopalan B; Sibson NR; Perry VH; Styles P
J Neurosci; 2000 Nov; 20(21):8153-9. PubMed ID: 11050138
[TBL] [Abstract][Full Text] [Related]
15. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats.
Anthony DC; Bolton SJ; Fearn S; Perry VH
Brain; 1997 Mar; 120 ( Pt 3)():435-44. PubMed ID: 9126055
[TBL] [Abstract][Full Text] [Related]
16. Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor.
Merchant RE; Merchant LH; Cook SH; McVicar DW; Young HF
Neurosurgery; 1988 Dec; 23(6):725-32. PubMed ID: 2851116
[TBL] [Abstract][Full Text] [Related]
17. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
Saijo N; Ozaki A; Ishihara J; Sakurai M; Sasaki Y; Takahashi H; Sano T; Hoshi A
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor.
Quagliarello VJ; Wispelwey B; Long WJ; Scheld WM
J Clin Invest; 1991 Apr; 87(4):1360-6. PubMed ID: 2010549
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.
Rice CD; Merchant RE
J Neurooncol; 1992 May; 13(1):43-55. PubMed ID: 1613537
[TBL] [Abstract][Full Text] [Related]
20. Netrin-1 Preserves Blood-Brain Barrier Integrity Through Deleted in Colorectal Cancer/Focal Adhesion Kinase/RhoA Signaling Pathway Following Subarachnoid Hemorrhage in Rats.
Xie Z; Enkhjargal B; Reis C; Huang L; Wan W; Tang J; Cheng Y; Zhang JH
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28526701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
